Michael (Mike) Pishvaian

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Perthera
    Date added:
    09/16/2024
    Date updated:
    09/28/2024
  • Attribution:
    Self
    Type of financial relationship:
    Patent
    Ineligible company:
    Perthera
    Date added:
    09/16/2024
    Date updated:
    09/28/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Seattle Genetics, Tesaro, Arcus Bio, Ideaya, Repare Tx, Novartis, Pfizer, Merck, Tizonia, Amgen, RenovoRx, Boerhinger Ingelheim, Astellas, Actuate, MEI Pharma, Elevation Oncology, Recursion Pharma
    Date added:
    09/16/2024
    Date updated:
    09/28/2024
Return to Sept. 27-28, 2024 - Symposium for Evolving Therapies and Drug Development in Oncology